Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Associação Brasileira de Ozonioterapia (ABOZ) is a Brazilian non-profit professional association dedicated to the promotion, regulation, and scientific development of ozone therapy. Established in 2006, the organization works to standardize clinical protocols and provides extensive training and certification for healthcare professionals across various disciplines, including medicine, dentistry, and veterinary science. ABOZ has been instrumental in advocating for the legal recognition of ozone therapy in Brazil, culminating in federal legislation (Law 14.648/2023) that authorizes its practice as a complementary treatment. The association also fosters research and organizes international congresses to advance the understanding of medical ozone's applications in pain management, wound care, and infectious diseases. It serves as a central hub for scientific exchange and regulatory advocacy for integrative medicine in South America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Associação Brasileira de Ozonioterapia.